Aubrai by Bio is projected to decline to $0.8333 by 2027, a -17% move from its current price of $1.00. AUBRAI is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell. Market sentiment sits at 27/100 (Fear) on the Fear & Greed Index.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via CoinGecko & CoinMarketCap · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 2 | $0.962 | $1.00 | $1.04 | -0.09% |
| Aug 3 | $0.9455 | $1.00 | $1.06 | -0.18% |
| Aug 4 | $0.9328 | $0.9994 | $1.07 | -0.26% |
| Aug 5 | $0.922 | $0.9985 | $1.08 | -0.35% |
| Aug 6 | $0.9126 | $0.9976 | $1.09 | -0.44% |
| Aug 7 | $0.9041 | $0.9967 | $1.10 | -0.53% |
| Aug 8 | $0.8963 | $0.9958 | $1.11 | -0.62% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.8963 | $0.9958 | $1.11 | -0.62% |
| Week 2 | $0.8527 | $0.9897 | $1.15 | -1.23% |
| Week 3 | $0.8196 | $0.9836 | $1.18 | -1.83% |
| Week 4 | $0.7918 | $0.9776 | $1.21 | -2.44% |
| Week 5 | $0.7676 | $0.9716 | $1.23 | -3.04% |
| Week 6 | $0.746 | $0.9656 | $1.25 | -3.63% |
| Week 7 | $0.7262 | $0.9596 | $1.27 | -4.23% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Aubrai by Bio is the world’s first decentralized scientific agent with knowledge stemming from thousands of private lab notes, internal chats and unpublished insights from the lab of Dr. Aubrey de Grey and the collective intelligence of the global longevity community. It sits at the intersection of Artificial Intelligence (AI), a Base Ecosystem, Decentralized Science (DeSci), AI Agents, x402 Ecosystem and Base Native, reflecting its multi domain role in the digital research landscape.
As an onchain AI co-scientist, Aubrai can generate and validate hypotheses, design wet-lab experiments and encrypt data when asked, enriching research outputs while protecting trade secrets. This combination of capabilities positions Aubrai as a collaborative tool for researchers and a novel kind of onchain intelligence product.
At the heart of Aubrai's mission lies the Robust Mouse Rejuvenation (RMR2) project – Aubrey's ambitious study to double the remaining lifespan of middle‑aged mice. If successful, it could be aging's AlphaFold moment: a proof that multi‑target rejuvenation works and is worth scaling.
Aubrai by Bio (AUBRAI) is a digital asset with a current price of $1.00 and a market cap of $1.43M. It holds a rank of 2490 by market capitalization. The asset has an all‑time high of $27.72 and an all‑time low of $0.5223. The price path ahead is outlined by year‑by‑year forecasts, with notable bullish signals around 2030, 2040 and 2050.
For longer horizon context, the forecast shows sustained average prices around the high single digits in the 2030s and beyond, with the 2030 average at $1.23, the 2040 average at $1.26 and the 2050 average at $1.22. These figures accompany varying ROIs and sentiment across the horizon, illustrating a landscape of potential growth tempered by volatility.
A major floor 25.7% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.1% away) — a key level to hold.
The nearest ceiling, 38.8% above — a clean break opens room to run.
A major ceiling 223.1% above — clearing it would confirm fresh momentum.
Key AUBRAI support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of AUBRAI market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.03 | Sell | $1.04 | Sell |
| MA 10 | $1.10 | Sell | $1.08 | Sell |
| MA 20 | $1.14 | Sell | $1.14 | Sell |
| MA 50 | $1.30 | Sell | $1.27 | Sell |
| MA 100 | $1.56 | Sell | $1.45 | Sell |
| MA 200 | $1.51 | Sell | $2.39 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 30.03 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -148.20 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | -10.73 | Sell |
| Bollinger %B (20,2) | 0.04 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -0.74 | Sell |
| Awesome (5,34) | -0.18 | Sell |
| Ultimate (7,14,28) | 16.41 | Buy |
| Momentum (10) | -0.20 | Sell |
| Aroon Osc (25) | -100.00 | Sell |
| Hull MA (9) | 0.97 | Buy |
| ADX (14) | 24.42 | Sell |
| ATR (14) | 0.03 | Info |
The 30‑day technical picture is neutral with RSI14 at 30. The short‑term moving averages point to near‑term price alignment with the midline, with the SMA50 listed at $1.33 and the SMA200 at $1.54.
On the price floor and ceiling, support sits at $1.00 and resistance at $1.39. The 30‑day price range spans from a low of $0.8056 to a high of $1.25, framing a narrow trajectory around the current level.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.5902 | $1.00 | $1.29 | 0% | Neutral | |
| $0.6303 | $0.8333 | $1.18 | -17% | Bearish | |
| $0.4446 | $0.6161 | $0.9235 | -39% | Bearish | |
| $0.4571 | $0.659 | $1.03 | -34% | Bearish | |
| $0.8217 | $1.23 | $1.99 | +22% | Bullish | |
| $0.6202 | $0.957 | $1.60 | -4% | Neutral | |
| $0.5238 | $0.8336 | $1.43 | -17% | Bearish | |
| $0.4441 | $0.7277 | $1.28 | -27% | Bearish | |
| $0.6798 | $1.15 | $2.05 | +14% | Neutral | |
| $0.8505 | $1.47 | $2.69 | +47% | Bullish | |
| $0.6403 | $1.26 | $2.51 | +26% | Bullish | |
| $0.5487 | $1.22 | $2.73 | +22% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.5902 | $1.00 | $1.35 | +0.00% |
| September 2026 | $0.8898 | $1.07 | $1.34 | +6.85% |
| October 2026 | $0.7602 | $0.9246 | $1.17 | -13.64% |
| November 2026 | $0.7562 | $0.9279 | $1.19 | +0.36% |
| December 2026 | $0.803 | $0.9934 | $1.29 | +7.05% |
Click any year to see its month-by-month AUBRAI forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Aubrai by Bio's 2026 outlook centres on $1.00, within a $0.5902 to $1.29 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, AUBRAI could reach as high as $1.18, with a base case around $0.8333 and support toward $0.6303 — roughly -17% from $1.00. A cyclical pullback looks likely — prices rarely move in a straight line.
Expect AUBRAI to range from $0.4446 to $0.9235 through 2028. The $0.6161 average target implies a -39% move from current prices. That is -26% versus the projected 2027 average. Expect choppier, lower action through this leg of the cycle.
The AUBRAI price prediction for 2029 points to an average of $0.659 (low $0.4571, high $1.03) — a potential decline of -34% on today's $1.00. A cyclical pullback looks likely — prices rarely move in a straight line.
In 2030, AUBRAI is projected to trade between $0.8217 and $1.99, averaging $1.23 — a potential gain of +22% from today's $1.00. That is up +86% on the projected 2029 average. Buyers look set to stay in control over this stretch.
Aubrai by Bio's 2031 outlook centres on $0.957, within a $0.6202 to $1.60 range. That is -22% versus the projected 2030 average. That marks a -4% change versus current levels. Price action looks broadly range-bound.
By 2032, AUBRAI could reach as high as $1.43, with a base case around $0.8336 and support toward $0.5238 — roughly -17% from $1.00. Expect choppier, lower action through this leg of the cycle.
Expect AUBRAI to range from $0.4441 to $1.28 through 2033. The $0.7277 average target implies a -27% move from current prices. That is -13% versus the projected 2032 average. A cyclical pullback looks likely — prices rarely move in a straight line.
The AUBRAI price prediction for 2034 points to an average of $1.15 (low $0.6798, high $2.05) — a potential gain of +14% on today's $1.00. A consolidation phase looks the most probable path here.
In 2035, AUBRAI is projected to trade between $0.8505 and $2.69, averaging $1.47 — a potential gain of +47% from today's $1.00. That is up +29% on the projected 2034 average. Momentum favours further upside here.
Aubrai by Bio's 2040 outlook centres on $1.26, within a $0.6403 to $2.51 range. That is -14% versus the projected 2035 average. That marks a +26% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, AUBRAI could reach as high as $2.73, with a base case around $1.22 and support toward $0.5487 — roughly +22% from $1.00. Momentum favours further upside here.
Investing $1,000 in AUBRAI today (≈ 998.003992 AUBRAI) could be worth
$1,216.8
+$216.8 (+22%) by 2050 · US Dollar
Based on the average projected AUBRAI price of $1.22 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in AUBRAIwould be worth at today's price.
$1,000 invested in AUBRAI on Aug 28, 2025 (≈ 91.013565 AUBRAI) would be worth
$91.2
-$908.8 (-90.9%) today · 0.09× · US Dollar
Based on a AUBRAI entry price of $10.99 vs. today's $1.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.19 | $844.16 | -15.6% |
| 1 month ago | $1.33 | $751.7 | -24.8% |
| 3 months ago | $3.71 | $270.15 | -73.0% |
| 6 months ago | $1.98 | $506.71 | -49.3% |
| All time ago | $10.99 | $91.2 | -90.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our AUBRAI forecast.
$2.00 is within our bullish range by 2034, but above the base case.
Implied market cap at $2.00: $2.86M
The multi‑year forecast paints a mixed but ultimately bullish arc beyond the mid‑2030s. In 2026 the average price is forecast at $1.00 with an ROI of 0 and a neutral sentiment. The subsequent years show a sequence of mixed signals through 2029, including bearish years in 2027, 2028 and 2029 with negative ROIs, followed by a notable shift in 2030 to an average of $1.23 and an ROI of 22.5 with bullish sentiment.
The forecast continues to show a transition through 2031 to 2033 with fluctuating averages and negative ROIs in several years (2031 ROI -4.5, 2032 ROI -16.8, 2033 ROI -27.4) before higher levels reemerge. By 2034 the average price is $1.15 with an ROI of 14.3 and neutral sentiment, and 2035 carries a stronger bullish signal with an average of $1.47 and ROI of 47. The longer horizon remains bullish with 2040 averaging $1.26 and ROI 25.8, and 2050 averaging $1.22 with ROI 21.7.
Overall, the forecast depicts a path where bear phases are interspersed with longer stretches of upside, culminating in higher averages in the 2030s and beyond. It is important to remember these are estimates, not guarantees, and reflect a range of possible outcomes influenced by market dynamics and the evolving adoption of Aubrai.
Tap a question to reveal the answer.
Average price in 2030 is $1.23, with a min of $0.8217 and a max of $1.99; ROI 22.5; sentiment BULLISH.
Forecasted maximums include 2035 at $2.69, 2040 at $2.51 and 2050 at $2.73.
The forecast shows a mix of bearish years (2027, 2028, 2029, 2032, 2033) and bullish years (2026, 2030, 2034, 2035, 2040, 2050) with ROIs ranging from -34.2 to 47.
Current price is $1.00 and market cap is $1.43M.
Annualized volatility is 80.
Aubrai by Bio Community Discussion
0Share your Aubrai by Bio price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.